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Cerebral small vessel disease (SVD) is a major contributor to stroke and dementia,
characterized by white matter hyperintensities (WMH) on neuroimaging. WMH are
associated with reduced cerebral blood flow (CBF) cross-sectionally, though longitudinal
associations remain unclear. We updated a 2016 systematic review, identifying 30 new
studies, 27 cross-sectional (n = 2,956) and 3 longitudinal (n = 440). Cross-sectionally,
10/27 new studies (n = 1,019) included sufficient data for meta-analysis, which we
meta-analyzed with 24 previously reported studies (n = 1,161), total 34 (n = 2,180).
Our meta-analysis showed that patients with lower CBF had worse WMH burden
(mean global CBF: standardized mean difference (SMD):−0.45, 95% confidence interval
(CI): −0.64, −0.27). Longitudinally, associations between baseline CBF and WMH
progression varied: the largest study (5 years, n = 252) found no associations, while
another small study (4.5 years, n = 52) found that low CBF in the periventricular WMH
penumbra predicted WMH progression. We could not meta-analyse longitudinal studies
due to different statistical and methodological approaches. We found that CBF was
lower in WMH than in normal-appearing white matter in an additional meta-analysis
(5 cross-sectional studies; n = 295; SMD: −1.51, 95% CI: −1.94, −1.07). These
findings highlight that relationships between resting CBF and WMH are complex. Further
longitudinal studies analyzing regional CBF and subsequent WMH change are required
to determine the role of CBF in SVD progression.
Keywords: cerebral blood flow, cerebral small vessel disease, stroke, white matter hyperintensities, systematic
review, meta-analysis
INTRODUCTION
Cerebral small vessel disease (SVD) develops from pathological changes in the blood vessels
supplying the brain and is an underlying cause of about 20% of all strokes and the most substantial
contributor to vascular dementia (1). Advances in neuroimaging have been key in identifying and
elucidating common features of SVD, including white matter hyperintensities (WMH), although
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much remains unknown about the underlying pathological
mechanisms and there are currently no effective treatments.
Vascular changes may occur before WMH are detectable,
and are thought to contribute to WMH development (2).
However, whether CBF reductions precede or follow WMH
progression remains controversial, as hypoperfusion could be
a consequence of WMH rather than the cause (3). WMH can
be reversible, therefore establishing initial processes involved in
WMH development may help identify targets to prevent SVD
progression and related pathology (4, 5).
Our previous systematic review and meta-analysis of WMH
and CBF found that more severe WMH burden was associated
with lower CBF, although this association weakened when studies
of patients with dementia and poor age matching of controls
were excluded (3). Age, dementia, and other vascular risk factors
contribute to CBF reductions and can confound the relationship
between WMH burden and CBF (3). Additionally, there were
few data on sub-regional brain tissue CBF and longitudinal
WMH changes in our previous review (3), as most studies only
examined whole brain and/or cortical CBF.
Since 2016, several studies have been published that provide
data on regional or tissue-specific CBF in WMH and normal
appearing white matter (NAWM) cross-sectionally (6–10) as well
as longitudinal studies, yet knowledge gaps remain regarding
the association between CBF and WMH. Therefore, we updated
our previous systematic review and meta-analysis (3) to identify
whether these gaps in the literature and previous inconsistencies
have been resolved.
MATERIALS AND METHODS
We updated our previous systematic review by Shi et al. (3),
covering from 1946 until December 2015, by conducting a
literature search of MEDLINE and EMBASE from 1st January
2016 up to 1st February 2020, using OVID. The search strategy
and methodological approach including quality assessment and
data extraction were as published by Shi et al. (3), combining
exploded search terms relating to small vessel disease and
cerebral blood flow with AND (Supplementary Figure 1). We
identified additional records by hand-searching, from January
2016 to February 2020, the Journal of Cerebral Blood Flow and
Metabolism and within the subject of Cerebrovascular Disease
and Stroke in Stroke.
Eligibility Criteria
We included longitudinal and cross-sectional studies
investigating associations between CBF or transit time metrics,
including arterial transit time (ATT) and mean transit time
(MTT), and WMH in patients with SVD, as well as studies
measuring CBF velocity (CBFv) using ultrasound Doppler. We
included studies using magnetic resonance imaging (MRI),
including with phase contrast, arterial spin labeling (ASL) or
dynamic susceptibility contrast, positron emission tomography
(PET), single-photon computed tomography and computed
tomography (CT) perfusion assessment. We excluded studies in
pediatric or animal populations, duplicates, conference abstracts
and cross-sectional studies lacking analysable data on CBF.
Data Extraction and Analysis
We screened all potentially eligible publications and extracted
standardized data from studies meeting the eligibility criteria.We
extracted data on the study population cohort, the type of study,
SVD characteristics, measurements, and units of CBF reported.
Where available, we extracted data on separate regional CBF
measurements forWMH, defined usingMRI or CT, and NAWM,
as this was previously identified as a key gap in the literature (3).
Where reported we also extracted data on associations between
ATT or MTT and WMH. We assessed the quality of each
included study using a checklist based on the Strengthening
the Reporting of the Observational studies in Epidemiology
(STROBE) criteria (11).
We extracted mean and standard deviation (SD) CBF
values from disease and control groups or according to
WMH burden, where available from text, tables, graphs or, if
necessary, Supplementary Material for cross-sectional studies.
We recorded associations with WMH burden either alone or
as a component of total SVD burden, such as the ordinal SVD
score which includes a point for central or cerebral atrophy,
lacunes and white matter hyperintensities when rated from CT
scans (12) with cerebral microbleeds also included for MRI (13).
We included cross-sectional studies with only qualitative data
or association analysis on CBF and SVD in the review but not
the meta-analysis. We also extracted association analysis data
from studies which performed association analysis in addition
to providing quantitative data. We extracted information from
longitudinal studies on time to follow-up, baseline and follow-up
measurements of CBF and WMH, and their associations. Where
unavailable in the published materials, we contacted authors to
request unpublished data on baseline and follow-up CBF and/or
WMH volume.
Meta-Analysis
We included all studies reporting mean and SD values for
CBF in patient groups by WMH burden in the cross-sectional
meta-analysis. In studies with more than two patient groups of
WMH severity, we took mean values to allow for a comparison
between patients with negative-to-mild and moderate-to-severe
WMH burden following a previously described procedure (3).
We extracted CBF values for gray and white matter in various
brain regions, as reported by individual studies. We calculated
standardized mean differences (SMDs) and 95% confidence
intervals (CIs) with a random effects model and analyzed new
data along with the data reported in our previous review (3).
We also extracted CBF values where available from WMH and
NAWM to perform an additional meta-analysis on regional
variability in CBF in different white matter tissues. Where
studies reported CBF values separately for periventricular WMH
(PVWMH) and deep WMH (DWMH), we took mean values
to give a measurement of CBF in WMH. We used Cochrane
Collaboration’s Review Manager (RevMan, RRID:SCR_003581,
version 5.4) to perform the meta-analyses.
RESULTS
We identified 783 articles published between January 2016
and February 2020 from the literature search, after removing
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duplicates (Figure 1). Of these, we identified 149 of potential
relevance and screened full texts to assess eligibility, 119 were
excluded primarily due to lack of analyzable data (45 studies), no
data on the association between WMH and CBF (38 studies) and
conference abstracts (33 studies). Overall, we included 30 studies
for qualitative analysis, of which 15 studies provided data for
FIGURE 1 | PRISMA flow diagram of literature search.
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meta-analysis (Figure 1). Of these 15, 10 cross-sectional studies
weremeta-analyzed with data previously extracted from 24 cross-
sectional studies published between 1946 and 2015 (3) while 5
studies were included in the additional meta-analysis of regional
variability in CBF within WMH and NAWM.
Some publications used the same study population cohort:
Promjunyakul et al. (14, 15) from the Layton Aging and
Alzheimer’s Disease Center longitudinal aging study and Turk
et al. (16, 17) with the same cohort of patients with ischemic
leukoaraiosis (ILA) and age, sex and risk-factor matched controls
without ILA.We ensured that each participant was only included
once in any single analysis.
Characteristics of Included Studies
We extracted data from 27 new cross-sectional (n = 2,956)
and 3 new longitudinal studies (n = 440). All the new studies
investigated patients or controls with varying degrees of WMH
burden. The characteristics of these 30 studies (n = 3,396)
are described in Table 1. The average study quality for all
identified studies according to the STROBE criteria was 6.5/9
(Supplementary Figure 2). Main reasons for lower overall study
quality scores included studies not reporting the number of
participants who dropped out (11/30), number and expertise of
WMH assessors (13/30) and a lack of blinding to imaging or
clinical data (14/30).
Seven of the 27 newly identified cross-sectional studies
investigated patients with cognitive impairment or dementia;
including Alzheimer’s disease (AD) (20, 23) mild cognitive
impairment (MCI) (8, 10, 22) and vascular cognitive impairment
(VCI) (9, 21).
Thirteen of the 27 added cross-sectional studies investigated
patients without cognitive impairment including patients with
varying degrees of WMH burden (7, 16, 24, 32), hypertensive
patients with and without SVD (6, 25, 29), individuals with
Cerebral Autosomal Dominant Arteriopathy with Sub-cortical
Infarcts and Leukoencephalopathy (CADASIL) (28), cognitively
normal older subjects (14, 27) and patients with ischemic stroke
(31). Two of these 13 studies investigated the effect of blood
pressure reduction on CBF in SVD, from which only baseline
data on CBF and WMH burden, prior to any treatment, were
extracted (26, 30).
Seven of the 27 new cross-sectional studies reported only the
results of association analyses and did not provide quantitative
data for CBF or WMH measurements. Patient groups in these
studies included patients with acute stroke (12, 33), MCI
(34), vascular depression (35), individuals at varying risk of
cerebrovascular disease (36), and older individuals with WMH
(17, 37).
The 3 newly identified longitudinal studies (n = 440)
investigated baseline CBF and WMH progression in older
individuals withWMH (Table 1), over follow-up periods ranging
from two (18) to five (19) years. While 2 studies investigated
associations between baseline WMH volume and change in
either subregional (15) or global (19) CBF, one study considered
associations between change in WMH volume and change in
cortical gray matter CBF (18).
Fifteen studies used ASL (6–8, 10, 14, 15, 18, 22, 23, 27, 29,
30, 34, 36, 37), 3 used CT perfusion (20, 26, 31), 2 used dynamic
susceptibility contrast (DSC) MRI (9, 19), one study each used
SPECT (21), phase contrast MRI (24), CT angiography/digital
subtraction angiography (33), PET (32), and a combination of
CT and DSC MRI (12). Five studies used transcranial Doppler
ultrasound (16, 17, 25, 28, 35).
Cross-Sectional CBF and WMH
Association
We extracted association analysis data from 11 of the new cross-
sectional studies overall, including the 7 studies which reported
association analyses without providing quantitative data and
4 studies which performed association analyses in addition to
providing quantitative data (6, 20, 27, 31). Only 5 of these
11 studies adjusted for key vascular risk factors, including
hypertension and smoking (12, 17, 33, 35, 36).
Cross-Sectional Association Analysis of
Global or Regional CBF and WMH
Four of the new studies analyzed associations between global or
regional CBF and WMH burden (Table 2). All of these studies
found that patients with a worse WMH burden had lower CBF
than those with a less severe WMH burden (20, 31, 33, 34), one
study showed that worse PVWMH, DWMH and whole-brain
WMH each showed a trend to be associated with lower CBF
both in patients with AD and controls without AD (n = 203)
(20).WorseWMHwere associated with poorer cerebral collateral
circulation, defined as cortical CBF at the outer surface of the
brain, in one study which investigated patients with acute stroke
(n= 178) (33).
Two of the new studies showed that lower mean blood flow
velocity (MBFv) in the internal carotid artery andmiddle cerebral
artery were associated with worse WMH burden in patients with
ischemic leukoaraiosis (n = 96) (17) and vascular depression (n
= 76) (35) (Table 2).
Cross-Sectional Association Analysis of
SVD Burden and Transit Time
Arba et al. (12) assessed SVD burden on CT or MRI, using
an SVD score and four transit time metrics (MTT, time to
maximum flow, time to peak, and arrival time fitted) derived
from perfusion CT or DSC MRI, in the asymptomatic cerebral
hemisphere of patients with acute ischemic stroke (n = 115).
Worse SVD scores were associated with more prolonged
transit times in white matter of the asymptomatic cerebral
hemisphere (i.e., contralateral to the acute ischemic stroke,
Table 2). SVD burden was also associated with reduced CBF in
the contralateral hemisphere.
Cross-Sectional Association Analysis of
CBF in WMH and NAWM
Three recently published studies found that CBF was lower
within WMH than in NAWM (Table 3). Higher WMH volume
in older patients with hypertension (n = 185) (6) was associated
with lower CBF within WMH. However, no clear relationship
Frontiers in Neurology | www.frontiersin.org 4 May 2021 | Volume 12 | Article 647848
Stewart et al. Associations in Small Vessel Disease
TABLE 1 | Characteristics of all studies included in this updated systematic review and meta-analysis.
Type of study Sample
size
Participants (Baseline) age





Staffaroni et al. (18) 136 Aging adults 69.9 ± 8.3 ASL ml/100 g/min
Promjunyakul et al. (15) 52 Cognitively healthy older participants 82.8 ± 7.6 ASL ml/100 g/min
Nylander et al. (19) 252 Older participants 75 DSC MRI Relative units
Cross-sectional: Cognitive impairment/dementia (7)
Wong et al. (9) 27 SVD patients 69 ± 12 DSC/ DCE MRI ml/min/100 g
Li et al. (20) 203 AD 70.49 ± 10.01 CT perfusion ml/100 g/min
Controls without AD 69.39 ± 8.10
Wu et al. (10) 73 Subcortical vascular MCI 65.71 ± 8.2 ASL ml/100 g/min
Ishibashi et al. (21) 75 VCI with WMH 79.1 ± 5.8 SPECT ml/100 g/min
VCI without WMH 76.5 ± 7.7
Rane et al. (8) 28 MCI cognitively normal 76.4 ± 7.1 ASL ml/100 g/min
Shokouhi et al. (22) 265 MCI (higher WMH vol) 64.4 ± 7.5 ASL ml/100 g/min
Controls (lower WMH vol) 63.1 ± 7.2
Benedictus et al. (23) 88 AD (median Fazekas Score 1) 65 ± 7 ASL ml/100 g/min
No cognitive impairment (13)
Shi et al. (24) 56 WMH grade 1–2 64.25 ± 7.76 Phase-contrast MRI ml/min/100 ml
WMH grade 3–4 69.11 ± 7.11
WMH grade 5–6 74.26 ± 8.39
Muller et al. (25) 107 Patients with high BP: with SVD 64 ± 13 TCD cm/s
Without SVD 45 ± 16
Kate et al. (26) 71 Leukoaraiosis present 71 ± 11.2 CT perfusion ml/100 g/min
Leukoaraiosis absent 65 ± 11.6
Dolui et al. (27) 497 CARDIA cohort 50.4 ± 3.5 ASL ml/100 g/min
Cognitively normal older participants* 73.3 ± 6.9
Jokumsen-Cabral et al.
(28)
47 CADASIL 57 ± 13 TCD cm/s
Age-matched controls 59 ± 16
Parfenov et al. (29) 73 EAH patients 50.2 ± 6.2 ASL ml/100 g/min
Healthy controls 49.1 ± 4.4
Croall et al. (30) 62 Severe SVD 69.3 ASL ml/min/100 g
Zhong et al. (7) 75 Leukoaraiosis 67.05 ± 9.62 ASL ml/100 g/min
Bivard et al. (31) 229 Ischemic stroke 68 CT perfusion ml/100 g/min
van Dalen et al. (6) 185 Older hypertensive patients 77 ± 2 ASL ml/100 g/min
Promjunyakul et al. (14) 82 Cognitively healthy older participants 84.13 ± 8.3 ASL ml/100
g-tissue/min/age
(years)
Hashimoto et al. (32) 22 SVD patients: Lower volume
WMH
69 ± 7 PET ml/100 g/min
Larger volume WMH 68 ± 8
Turk et al. (16) 93 ILA 54.5 ± 8.1 TCD cm/s
Sex and risk factor matched controls 52.30 ± 6.05
Studies only performing association analysis (7)
Mark et al. (33) 178 Acute stroke: Good collateral grade 63.9 ± 14.7 CT angiography and
DSA
Not shown
Moderate collateral grade 73.1 ± 12.3
Poor collateral grade 70.1 ± 15.5
Kim et al. (34) 38 MCI 68.4 ± 6.28 ASL ml/100 g/min
Cognitively healthy 68.25 ± 5.84
Puglisi et al. (35) 76 Vascular depression: WML group 1 71.95 ± 4.55 TCD (MBFv) Not shown
(Continued)
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TABLE 1 | Continued
Type of study Sample
size
Participants (Baseline) age




WML group 2 71.81 ± 4.71
WML group 3 73.96 ± 6.71
Bahrani et al. (36) 26 High-risk CVD 83 ± 4.6 ASL Relative units
Low-risk CVD 72.7 ± 4.2
Shi et al. (37) 69 Older participants with WMH 70.78 ± 3.94 ASL Relative units
Arba et al. (12) 115 Acute ischemic stroke 81 CT perfusion/ DSC MRI Not shown
Turk et al. (17) 96 ILA 54.90 ± 8.27 Ultrasound doppler mm3/s
Age, sex and risk-factor matched
controls
52.39 ± 7.34
S.D, standard deviation; CBF, cerebral blood flow; ASL, arterial spin labeling; DSC MRI, dynamic susceptibility contrast magnetic resonance imaging; SVD, small vessel disease;
DCE, dynamic contrast enhanced; CT, computed tomography; AD, Alzheimer’s disease; MCI, mild cognitive impairment; VCI, vascular cognitive impairment; SPECT, single Photon
Emission Computed Tomography; BP, blood pressure; TCD, transcranial doppler; CARDIA, coronary artery risk development in young adults study; *cognitively normal older individuals,
this group have significantly higher normalized WMH volumes compared to the CARDIA cohort; CADASIL, cerebral autosomal dominant arteriopathy with subcortical infarcts and
leukoencephalopathy; EAH, essential arterial hypertension; PET, positron emission tomography; ILA, ischemic leukoaraiosis; DSA, digital subtraction angiography; MBFv, mean blood
flow velocity; WML, white matter lesion; CVD, cerebrovascular disease.
was seen between WMH volume and CBF in NAWM or gray
matter (Table 3). Cognitively healthy older participants and
healthy middle-aged participants (n = 497) showed significantly
lower CBF within WMH compared to normal appearing white
matter (27). Similarly, in one small study (n= 26), CBF was lower
within DWMH and PVWMH compared to NAWM (36). In
contrast, one exploratory study (37) in healthy older participants
(n = 69) found in white matter regions where most patients had
WMH; higher WMH burden correlated with higher gray matter
perfusion in the opposite cerebral hemisphere.
Sensitivity Analyses of Age, Dementia, and
Key Vascular Risk Factors
We further refined the cross-sectional association analyses by
removing studies investigating patients with dementia, studies
without age-matching and studies which did not adjust for key
vascular risk factors. The direction of effect in the remaining
studies did not change: lower blood flow velocity (17, 35)
and prolonged perfusion CT/DSC transit time metrics (12)
remained associated with WMH, as well as lower CBF within
WMH compared to NAWM (36). Only one cross-sectional
study investigated WMH in association with global or regional
CBF while adjusting for key vascular risk factors, showing
worse WMH was associated with poorer collateral blood
flow (33).
Longitudinal Analyses of CBF and WMH
The largest of the three new longitudinal studies (19) in a
cohort of 406 randomly selected 75-year-old participants at
baseline and 252 at follow-up, found no significant association
between baseline CBF with WMH progression at a five-year
follow-up when adjusting for baseline WMH and sex (Table 4).
In 136 functionally normal older individuals, Staffaroni et al.
(18) found that longitudinal reductions in global CBF were
associated with increasing WMH burden, adjusting for age, sex
and education. Promjunyakul et al. (15), in 52 cognitively healthy
older participants, found that lower baseline CBF within the
PVWMHpenumbra was associated withWMHgrowth at follow-
up, while reduced white matter perfusion remained predictive
of PVWMH but not DWMH progression, adjusting for age
and sex. These 440 patients from the three recent longitudinal
studies add to the 1,079 patients in 4 studies included in our
2016 review (3). Summarizing all 7 longitudinal studies (n =
1,519), the two largest studies (total n = 827, 575 + 252)
found low baseline CBF did not predict worsening WMH; one
previous and one new study (n = 390 + 136) found low CBF
predicted increased PVWMH but not deep WMH progression
or predicted global WMH; the two smallest studies (n = 40 and
52) found low CBF in NAWM/penumbral tissue predatedWMH
growth at follow-up; and one prior study (n = 74) found CBF
increased in some regions and decreased in other regions as
WMH progressed.
Longitudinal meta-analysis was not possible due to
insufficient data and different statistical and methodological
approaches between studies. The two studies with follow-up
CBF measures (18, 38) carried out their statistics differently and
therefore could not be combined.
Cross-Sectional Meta-Analysis of CBF and
WMH Burden
We included 34 cross-sectional studies (n = 2,180) in this
updated meta-analysis, of which 24 had been previously
identified in our 2016 review (3). The 10 newly identified studies
covered 4 brain regions, including mean global CBF (20, 21, 24,
29), mean basal ganglia blood flow (32), total gray matter (6, 22)
and centrum semiovale (32) (Figure 2A). We extracted data
on CBF velocity, as measured from the middle cerebral artery
(vMCA) (16, 25, 28) and included this under a new subgroup in
the meta-analysis. We found no additional published data for 7
brain regions included in our previous review (3): four in gray
matter (frontal, temporal, parietal, and occipital) and three in
white matter (total, frontal, and occipital).
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Coefficients P-values Adjusted for other
variables
(A) Global or regional CBF association with WMH
Bivard et al. (31) 229 Linear regression model Hypoperfusion and
likelihood of WMH
OR = 7.61 <0.001 No
Kim et al. (34) 38 Linear regression analysis Mean parietal lobe CBF and
WMH volume
t(15) = −3 0.009 Gender
Mean temporal lobe CBF
and WMH volume
t(15) = −3.89 0.001
Mean occipital lobe CBF
and WMH volume
t(15) = −4.71 0.001
Mean frontal lobe CBF and
WMH volume
t(15) = −2.58 0.021
Li et al. (20) 203 Spearman correlation
analysis
Whole-brain WMH severity
and CBF (AD patients)
r = −0.162 0.068 Not shown
PVWMH severity and CBF
(AD patients)
r = −0.219 0.013
DWMH severity and CBF
(AD patients)
r = −0.099 0.268
Whole-brain WMH severity
and CBF (controls)
r = −0.034 0.071
PVWMH severity and CBF
(controls)
r = −0.071 0.546
DWMH severity and CBF
(controls)
r = −0.003 0.978
Mark et al. (33) 178 Multivariate logistic
regression analysis
PVWM Fazekas score and
collateral flow




failure and smoking history
DWM Fazekas score and
collateral flow
NA <0.0001
Total Fazekas score and
collateral flow
NA <0.0001
(B) Mean blood flow velocity association with WMH
Turk et al. (17) 96 Spearman’s correlation
coefficient
Correlation of average mean
blood flow in ICA (mm3/s)
with ILA
Spearman’s p = −0.232 0.025 Age, gender, and CVD risk
factors
Logistic regression Association of average
mean blood flow in ICA
(mm3/s) with ILA
OR = 0.577 (0.368–0.902) 0.016
Puglisi et al. (35) 76 Spearman correlation Correlation between MBFv
in MCA and WMH severity
r = −0.34 0.002 Demographic variables and
clinical variables (including
vascular risk factors)
(C) Transit time association with SVD burden
Arba et al. (12) 115 Logistic regression model SVD score and mean transit
time
OR = 2.80 (1.56–5.03) <0.05 Age, NIHSS, sex,
hypertension, and diabetes
SVD score and time to
maximum flow
OR = 2.36 (1.37–4.09) <0.05
SVD score and time to peak OR = 1.52 (0.93–1.05) N.S.
SVD score and arrival time
fitted
OR = 3.59 (1.92–6.75) <0.01
WMH, white matter hyperintensity; OR, odds ratio; CBF, cerebral blood flow; AD, Alzheimer’s disease; PVWMH, periventricular white matter hyperintensity; DWMH, deep white matter
hyperintensity; PVWM, periventricular white matter; DWM, deep white matter; NA, not available; ICA, internal carotid artery; ILA, ischemic leukoaraiosis; OR, odds ratio (95% confidence
interval); CVD, cerebrovascular disease; MBFv, mean blood flow velocity; MCA, middle cerebral artery; SVD, small vessel disease; N.S, not significant; NIHSS, National Institutes of
Health Stroke Scale. P-values < 0.05 are shown in bold.
Of the four regions where additional data was identified,
patients with moderate-to-severe WMH burden had lower
CBF than those with negative-to-mild WMH burden in three
regions: global CBF (SMD: −0.45, 95% CI: −0.64, −0.27),
total gray matter (SMD: −0.37, 95% CI: −0.69, −0.05) and
centrum semiovale (SMD: −1.25, 95% CI: −1.96, −0.54)
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Coefficients P-values Adjusted for other
variables
Bahrani et al. (36) 26 Post-hoc paired
comparisons
CBF in DWMH compared to NAWM t = 5.7 <0.001 Age, vascular risk group,
total intracranial volumeCBF in PVWMH compared to NAWM t = 11 <0.0001
CBF in PVWMH compared to DWMH t = 3.1 0.003




WMH volume and NAWM CBF β = 0.175 0.098
WMH volume and GM CBF β = 0.175 0.133
Dolui et al. (27) 497 Two-way repeated
measures ANOVA
Mean CBF inside WML compared to
outside (ADC cohort)
partial η2 = 0.75 <0.0001 No
Mean CBF inside WML compared to
outside (CARDIA cohort)
partial η2 = 0.59 <0.0001
Shi et al. (37) 69 Pearson correlation WMH ROI (R hemisphere) and CBF
ROI (L hemisphere)
r = 0.42 0.00045 Age, sex,
education-adjusted MoCA
score, total WMH volumeWMH ROI (L hemisphere) and CBF
ROI (R hemisphere)
r = 0.43 0.00037
CBF, cerebral blood flow; WMH, white matter hyperintensity; NAWM, normal appearing white matter; DWMH, deep white matter hyperintensity; PVWMH, periventricular white matter
hyperintensity; GM, gray matter; β, standardized estimate in linear regression; WML, white matter lesion; ADC, Alzheimer’s Disease Center (this is a longitudinal, prospective cohort and
the individuals are cognitively healthy); CARDIA, Coronary Artery Risk Development in Young Adults study; ROI, region of interest; R, right; L, left; MoCA, Montreal cognitive assessment.
P-values < 0.05 are shown in bold.
TABLE 4 | Results from longitudinal studies.
Nylander et al. (19) Staffaroni et al. (18) Promjunyakul et al. (15)
Sample size 252 136 52
Follow-up time (years) 5 2.3 4.5
CBF At baseline NA 27.07 ± 6.38* WM CBF: 27.0 ± 6.6
GM CBF: 59.3 ± 10.0
PVWMH CBF: 14.09 ± 6.05
DWMH CBF: 16.12 ± 6.85
CBF At follow-up NA 24.47 ± 5.61* NA
WMH (ml) At baseline 10.5 ± 5.2 (n = 406) 3.4 ± 3.8* Mean PVWMH vol. = 10.3 ± 11.7
Mean DWMH vol. = 1.6 ± 1.2
WMH (ml) At follow-up 11.9 ± 5.7 (n = 229) 4.6 ± 4.8 * Mean PVWMH vol. growth = 3.7 ± 6 ml
Mean DWMH vol. growth = 0.4 ± 1 ml
Baseline CBF and baseline WMH volume Coefficient NA ß = −0.08, b = −0.01 NA
P-value N.S. 0.358
Baseline CBF and 1WMH volume Coefficient NA NA NA
P-value N.S.
Baseline WMH volume and 1CBF Coefficient NA NA NA
P-value
1WMH volume and 1CBF Coefficient NA b = −0.02 NA
P-value 0.007
Adjusted for other variables Baseline value, sex Age, sex, education Age, sex
CBF, cerebral blood flow; WM, white matter; GM, gray matter; PVWMH, periventricular white matter hyperintensity; DWMH, deep white matter hyperintensity; WMH, white matter
hyperintensity; vol., volume; standardized beta (ß) and unstandardized (b), estimates given for linear regression models; bCBF, baseline CBF; bWMH, baseline WMH; 1WMH, change
in WMH; 1CBF, change in CBF; NA, not available.
*Unpublished data received from author upon request.
(Figure 2B). In the basal ganglia there was no difference in CBF
between patients with moderate-to-severe and negative-to-mild
WMH burden (SMD: −0.86, 95% CI: −1.97, 0.25). Participants
with worse WMH burden had lower blood flow velocities
in the middle cerebral artery (SMD: −0.34, 95% CI: −0.64,
−0.05).
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FIGURE 2 | Continued
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FIGURE 2 | (A,B) Forest plot showing standard mean differences in global, gray matter, and white matter cerebral blood flow and in blood flow velocity in the middle
cerebral artery. Cerebral blood flow was analyzed in subgroups according to brain regions. Additional studies identified since our previous meta-analysis are outlined,
all other data was originally published by Shi et al. (3). CBF, cerebral blood flow; WMH, white matter hyperintensity; vMCA, blood flow velocity in middle cerebral artery.
Sensitivity Analyses of Age and Dementia
As with our previous review (3), the difference in CBF
between patients with moderate-to-severe and negative-to-
mild WMH burden attenuated and became non-significant
upon removing studies investigating patients with dementia
and further removing non-age matched studies from the
updated meta-analysis, apart from mean global CBF and
centrum semiovale CBF (Supplementary Figures 3, 4). Mean
middle cerebral artery blood flow velocity was not significantly
different on comparing individuals with moderate-to-severe
and negative-to-mild WMH burden after excluding non-
age matched studies. Seven of the ten additional studies
were included in the meta-analysis after removing studies
which investigated patients with dementia and/or without
age-matching; and the studies included in the mean basal
ganglia and centrum semiovale categories did not differ, i.e.,
none of these studies included patients with dementia/without
age-matching.
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FIGURE 3 | Forest plot of the additional meta-analysis, showing standard mean differences in CBF in WMH compared to NAWM in subjects with moderate to severe
WMH burden. WMH, white matter hyperintensity; CBF, cerebral blood flow; NAWM, normal appearing white matter.
Cross-Sectional Meta-Analysis of CBF
Difference Between WMH and NAWM
Additional to the analyses that were possible in 2016, we found
sufficient data for meta-analysis in five recent cross-sectional
studies reporting CBF values for both WMH and NAWM in
subjects with moderate to severe WMH burden (n = 295). CBF
was lower in WMH compared to NAWM (SMD: −1.51, 95% CI:
−1.94,−1.07) (Figure 3).
DISCUSSION
We identified 30 new relevant publications since 2016, providing
a total additional sample of 3,396 (cross-sectional n = 2,956
+ longitudinal n = 440). The newly identified cross-sectional
studies reported lower CBF in most patients with higher WMH
burden, supporting previous findings (3). In an additional meta-
analysis, we confirmed that CBF was also lower in WMH than in
NAWM. Longitudinal findings were mixed, the largest studies (n
= 575+ 252) found baseline global CBF was not associated with
WMH progression (19), as such there is no definite association
between low CBF and increasing WMH long term. However,
regional associations between lower CBF andWMH progression,
notably in normal-appearing tissue surrounding PVWMH (n =
390+ 52) (15, 38) may exist.
Higher WMH burden was also associated with a lower blood
flow velocity in the middle cerebral artery, which could be
an important contributor to hypoperfusion (17, 35). Although
blood flow measurements from the middle cerebral artery are
less representative of CBF compared to CT and MRI-based
imaging methods, there is a dynamic relationship between
middle cerebral artery blood flow and blood flow in the cerebral
small vessels (39). Therefore, flow measurements from the large
arteries can be informative of cerebrovascular blood flow (40).
An association between impaired hemodynamics in the middle
cerebral artery and WMH has previously been established,
however there may be a stronger association with higher
pulsatility and WMH compared to lower blood flow velocity
and WMH (41). One cross-sectional study showed that higher
SVD burden was associated with prolonged MTT on CT and
DSC (12).
The heterogeneity of study populations can be an important
confounder, particularly in terms of age, sex and vascular risk
factors. Only a minority (5/11) of cross-sectional studies and
none of the longitudinal studies adjusted for cardiovascular
risk factors. Cardiovascular risk factors can influence the
development and rate of progression of SVD, while also
affecting CBF via several mechanisms (42). Hypertension is an
established risk factor for WMH that may affect CBF through
vascular morphological changes and lumen narrowing, which
can contribute to hypoperfusion (43). One cross-sectional study
(n = 73) found cerebral perfusion was lower in patients with
hypertension, with or without WMH, than in healthy controls,
though sample size was limited (29). Meanwhile, diabetes has
been linked to increased blood viscosity and a reduction in
deformability of erythrocytes proportional to the degree of
microvascular complications (44), white matter CBF is also lower
in patients with type 2 diabetes than in controls (45). As such,
controlling for cardiovascular risk factors is crucial in avoiding
potential confounds.
Strengths and Limitations
Strengths of this work include the thorough meta-analysis of
regional CBF variability by WMH burden, obtained through
updating previous work (3). The sample size for studies included
in the cross-sectional meta-analysis was enhanced (n = 2,180,
64/study). We also screened non-English language publications,
including a paper published in Russian (29). Limitations of this
work include the lack of additional data in some brain subregions,
though attempts were made to contact several authors to acquire
unpublished data. However, this may also reflect a narrowing
focus to key regions based on experimental hypotheses, excluding
regions which are less reproducible. The meta-analysis of CBF
variability inWMHandNAWMwas limited by the small number
of studies available (5), although the average sample size was
reasonable (n = 295, mean 59/study). Several studies lacked
control participants with little to no WMH burden and so
could not be included. Longitudinal studies remain very limited
and used heterogeneous methods, preventing direct comparison
and longitudinal meta-analysis. Follow-up CBF measurements
were only reported in 2 longitudinal studies (18, 38), thus
interpretation of CBF changes over time in association with
WMH progression is limited. However, an increasing use of
non-contrast perfusion methods, particularly ASL, should make
longitudinal imaging more viable. The role of other SVD
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markers, including lacunes and enlarged perivascular spaces, is
also underexplored. Lastly, the accuracy of white matter and
WMH perfusion measurements using ASL remains unclear, due
to the lower perfusion level and signal-to-noise ratio relative
to gray matter. This can be particularly relevant for older
patients with cerebrovascular disease, where lower perfusion is
more difficult to quantify. However, there are on-going efforts
to improve sensitivity of acquisition and analysis techniques
(46). Additionally, none of the included ASL studies measured
ATT, perhaps because ATT quantification requires a longer
acquisition (47).
Interpretation in Relation to CBF and WMH
Pathology
WMH and NAWM CBF variability remains underexplored
and more detailed longitudinal studies evaluating subregional
changes in tissue CBF and WMH progression are needed.
CBF reductions were more severe within WMH compared to
NAWM in patients with moderate-to-severe WMH burden,
suggesting WMH represent areas of focal perfusion deficits
which are more severe than global hypoperfusion. However,
associations with CBF may also be affected by other mechanisms
implicated in WMH evolution (48). Two cross-sectional studies
suggested that perfusion may be higher with higher WMH
burden in normal-appearing white and some gray matter regions
(6, 37), but were non-conclusive. Compensatory mechanisms
may also affect regional perfusion, with areas of increased
perfusion potentially counteracting deficiencies elsewhere (49).
However, it is unclear whether compensatory perfusion changes
would be sustained if they do occur, and could instead
indicate dysfunctional blood flow regulation with worse WMH
burden. Replication and more detailed subregional analyses
of tissue changes in larger cohorts over time are required.
Subtle regional differences in perfusion may also be masked
within larger regions (15). The selection of regions of interest
should therefore be considered carefully, and may favor finer
grained regions, such as stratifying tissue by proximity to
existing WMH (50) or other pathological features. We suggest
that future studies investigating associations between WMH
and perfusion should include the following key features as a
minimum standard: discrimination of flow values in WMH from
NAWM, as well as the reporting of vascular risk factors and
the inclusion of age-matched controls to avoid these variables
confounding the understanding of the relationship between
WMH and CBF.
Different vascular pathologies are thought to underlie
PVWMH and DWMH, with PVWMH more likely to result
from hemodynamic insufficiency, while DWMH are more
likely to be a consequence of SVD (51). Moreover, PVWMH
and DWMH have been demonstrated to show different
associations with various cardiovascular risk factors, further
suggesting different underlying pathologies (52). This highlights
the importance of conducting a region-dependent analysis
of WMH. Of the 11 cross-sectional studies investigating
the association between WMH and CBF included in this
review, only 3 of these studies provided separate regional
analysis for PVWMH and DWMH, while only 1 of the 3
longitudinal studies provided separate data for PVWMH and
DWMH. This lack of region-dependent analyses of WMH
limits the interpretation of the association with CBF, given the
differences in underlying pathophysiology between PVWMH
and DWMH.
Implications for Future Research
In conclusion, this systematic review and meta-analysis
showed that CBF was lower in most gray and white matter
regions of the brain with higher WMH burden and lower in
WMH than normal appearing white matter. Further studies
investigating CBF along with ATT may help give a more
comprehensive understanding of causal and consequential
effects in WMH development and progression. Longitudinal
studies exploring the effect of CBF changes on WMH
burden remain limited. Further longitudinal studies are
required to better understand the role of perfusion in
WMH development and evolution. Future studies should
also adjust for key vascular risk factors known to influence
CBF, particularly hypertension, and, where relevant, baseline
WMH burden.
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